跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CORTIMENT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CORTIMENT
Authorized
STANDARD
CORTIMENT
Ferring Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0ecf46b89d8eea37
Company
Ferring Inc
Type
Standard
Approval Details
Approval Id
0ecf46b89d8eea37
Drug Approval Canada Name
CORTIMENT
Product Name
CORTIMENT
Status
Marketed
Status Date
2016-07-25
Original Market Date
2016-07-25
Din
02455889
Drug Class
Human
Dosage Form
Tablet (Delayed And Extended Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:04.00
Atc Original
A07EA06 BUDESONIDE
Atc Name
a 07 ea 06
Aig Number
0116807012
Company Name
Ferring Inc
Company Address
500, 200 Yorkland Blvd, Toronto, Ontario, Canada, M2J 5C1
Active Ingredients
BUDESONIDE
9 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0ecf46b89d8eea37
Type
Standard
Back to Health Canada Approvals